Cardinal Health Stock Screens as Overvalued After Home Care Deal Push

Corporate Action
โดย Simply Wall St·Read original
Summary · why it matters

Cardinal Health stock appears overvalued on earnings following its push into home-based care through planned acquisitions of Strive Medical and AdaptHealth's diabetes business. The stock trades at about 35.0 times earnings, above the healthcare industry average of roughly 26.9 times and a peer group average of about 28.1 times, and above a modeled fair P/E ratio near 29.2 times. While the home care deals may support growth expectations, integration and regulatory risks could weigh on value, and the stock passes only two of six broader valuation checks. The premium suggests investors are already pricing in optimism around the acquisitions, leaving new buyers reliant on strong execution rather than valuation support.

Impact on stocks 2

Health Care▼ · 1 stocks
Cardinal Health Inc
CAH
▼ NegativeCapitalrelevance

Cardinal Health stock is deemed overvalued on earnings, trading at a premium above industry and peer averages, with only two of six valuation checks passing.

Aging Population▲ · 1 stocks
Adapthealth Corp
AHCO
± MixedCapitalrelevance

AdaptHealth's diabetes business is being acquired by Cardinal Health, but the article focuses on Cardinal's valuation, not AdaptHealth's prospects.

Off-coverage companies 1

Strive MedicalPrivate± Mixed
Capitalrelevance

Strive Medical is being acquired by Cardinal Health, but the article does not discuss Strive's own valuation or performance.

© 2026 MarketDXNews